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effects of H2S on tissue stability and viability, and opti-
mize conditions for transplantation and for the eventual
induction of immunotolerance to composite tissue
allotransplants.
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Should Endovenous Ablation of Small Diameter Great
Saphenous Veins Be Performed on Patients with Symp-
tomatic Varicose Veins?
Steven Perrins, Andrew Cha, Dahlia Plummer, Richard
Hsu, Alan M. Dietzek. Surgery, Danbury Hospital, Dan-
bury, CT
Objectives: The efficacy of radiofrequency ablation
(RFA) for symptomatic varicose veins is well established.
Alternatively, there is less consensus and little data on
outcomes when treating great saphenous veins (GSV) of
small diameter (5mm). To this point, there are national
insurance carriers that deny coverage for endovenous abla-
tion for patients with small GSV citing lack of proven
benefit. The purpose of this study is to assess clinical and
anatomical outcomes of RFA on small diameter, symptom-
atic GSV at 3 months.
Methods: A retrospective analysis was performed of
our patients who received RFA of incompetent GSV with-
out any concomitant adjunctive procedures between Janu-
ary 2008 and December 2011. Limbs with a maximum
GSV thigh diameter5mm on duplex while standing were
subject to review. Clinical success was defined as an im-
provement in Venous Clinical Severity Score (VCSS) at 3
months. Anatomic success was defined as absence of venous
flow 3cm distal to the saphenofemoral junction (SFJ) on
duplex ultrasound examination. Changes in CEAP class
were noted.
Results: In 307 patients, 54 limbs in 44 patients met
inclusion criteria. Baseline median VCSS was 4 (interquar-
tile range 4, 5). Clinical success was seen in 83% of limbs at 3
months with amedianVCSS change of -2 (IQR -3, -1).None
of the treated limbs had phlebectomy for symptomatic vari-
cosities prior to 3 month follow-up. One phlebectomy was
performed for cosmesis at 78 days post procedure. Anatomic
success was achieved in 96% of limbs at 3 months. Baseline
medianCEAPwas 2 (IQR2, 2). ThemedianCEAPchange at
3 months was 0 (IQR -1, 0).The only complication was a
thrombus extension into the SFJ at 4 days.
Conclusions: In our experience, RFA of symptomatic
small diameter GSV provides comparable clinical and ana-
tomic outcomes to that of current published data. Our
findings suggest that these patients benefit clinically from
the RFA procedure and should not be denied this treat-
ment based upon vessel diameter alone.
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Kevin C. Chun, Kai Y. Teng, Elyse N. Van Spyk, John G.
Carson, Eugene S. Lee. University of California, Davis and
Sacramento VA Medical Center; Sacramento, CA
Objectives: In 2007, Medicare guidelines were estab-
lished to identify persons at risk for the presence of an
abdominal aortic aneurysm (AAA). The purpose of this
study was to evaluate the implementation of the SAAAVE
Act in identifying patients at risk for AAA within a 5-year
period in clinical practice.
Methods: Data was extracted from a regional Veterans
Affairs Healthcare Network to identify all veteran males
65-75 years of age who smoked greater than 100 cigarettes
during their lifetime. In 2007, a AAA screening mandate
was implemented allowing patients meeting screening cri-
teria to be evaluated for AAA as part of the patient’s health
maintenance. AAA is identified as an aortic diameter size of
3.0 cm or greater. Clinician adherence to screening proto-
cols and timely referral for aneurysms greater than 5.5 cm
were also evaluated.
Results: A total of 9788 patients (71.5  5.6 years of
age) were screened for an AAA over a 5 year period from
January 1, 2007 to December 31, 2011. A total of 698
aneurysms (7.1%) were found (See Table). Timely referrals
were made on 44 patients with aneurysms greater than 5.5
cm. A total of 2828 patients (28.9%) were inappropriately
screened: 421 patients were too young, 2250 patients were
too old, 36 patients were women, and 121 patients without
aneurysms had multiple screenings.
Conclusions: The long implementation of the AAA
screening has allowed greater deviation from Medicare
guidelines that increased the number of inappropriate
screenings, mandating further AAA screening education for
primary care providers.
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